Published in Pediatr Res on May 01, 2001
Phenylbutyrate therapy for maple syrup urine disease. Hum Mol Genet (2010) 1.05
Variant maple syrup urine disease (MSUD)--the entire spectrum. J Inherit Metab Dis (2006) 1.04
Duration of extracorporeal therapy in acute maple syrup urine disease: a kinetic model. Pediatr Nephrol (2006) 0.80
Atypical phenotype in a boy with a maple syrup urine disease. J Inherit Metab Dis (2006) 0.75
Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop. J Inherit Metab Dis (2009) 1.58
Betaine in the treatment of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency. Eur J Pediatr (1984) 1.47
Hydrocephalus internus in two patients with 5,10-methylenetetrahydrofolate reductase deficiency. Neuropediatrics (2000) 1.44
Glutaric aciduria type II: report on a previously undescribed metabolic disorder. Clin Chim Acta (1976) 1.44
The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a. Eur J Hum Genet (1999) 1.42
Proton MR spectroscopy of the lumbar spine in patients with glycogen storage disease type Ib. J Magn Reson Imaging (2001) 1.37
Management and outcome in 75 individuals with long-chain fatty acid oxidation defects: results from a workshop. J Inherit Metab Dis (2009) 1.30
Prevalence of coeliac disease in diabetic children and adolescents. A multicentre study. Eur J Pediatr (1988) 1.22
Demyelination and decreased S-adenosylmethionine in 5,10-methylenetetrahydrofolate reductase deficiency. Neurology (1988) 1.15
Changes in blood carnitine and acylcarnitine profiles of very long-chain acyl-CoA dehydrogenase-deficient mice subjected to stress. Eur J Clin Invest (2004) 1.13
DNA haplotype analysis at the phenylalanine hydroxylase locus in the Turkish population. Hum Genet (1989) 1.12
Clinical and biochemical characteristics of congenital disorder of glycosylation type Ic, the first recognized endoplasmic reticulum defect in N-glycan synthesis. Ann Neurol (2000) 1.09
Standardized method for high-resolution 1H-NMR of cerebrospinal fluid. Clin Chem (1995) 1.08
Rapid diagnosis of maple syrup urine disease (branched chain ketoaciduria) by micro-enzyme assay in leukocytes and fibroblasts. Clin Chim Acta (1973) 1.07
Social outcome in adults with maple syrup urine disease (MSUD). J Inherit Metab Dis (2007) 1.07
Multiple acyl-Co A dehydrogenation deficiency (MADD) in a boy with nonketotic hypoglycemia, hepatomegaly, muscle hypotonia and cardiomyopathy. Detection of N-isovalerylglutamic acid and its monoamide. Helv Paediatr Acta (1983) 1.05
Variant maple syrup urine disease (MSUD)--the entire spectrum. J Inherit Metab Dis (2006) 1.04
Lethal infantile mitochondrial disease with isolated complex I deficiency in fibroblasts but with combined complex I and IV deficiencies in muscle. Neurology (1996) 1.04
Pregnancy in a woman with maple syrup urine disease. J Inherit Metab Dis (1998) 1.03
Evidence for impaired gluconeogenesis in very long-chain acyl-CoA dehydrogenase-deficient mice. Horm Metab Res (2006) 1.02
Alpha-ketoadipic aciduria: degradation studies with fibroblasts,. Clin Chim Acta (1975) 1.02
Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. Mol Genet Metab (2004) 1.02
Maple syrup urine disease: metabolic decompensation monitored by proton magnetic resonance imaging and spectroscopy. Ann Neurol (1993) 1.01
A patient with alpha-ketoadipic and alpha-aminoadipic aciduria. J Inherit Metab Dis (1984) 0.99
Alpha-ketoadipic aciduria, a new inborn error of lysine metabolism; biochemical studies. Clin Chim Acta (1975) 0.99
Severe neurological crisis in a patient with hereditary tyrosinaemia type I after interruption of NTBC treatment. J Inherit Metab Dis (2008) 0.99
Branched-chain L-amino acid metabolism in classical maple syrup urine disease after orthotopic liver transplantation. J Inherit Metab Dis (2000) 0.97
Antibiotic therapy for improvement of metabolic control in methylmalonic aciduria. J Pediatr (1990) 0.97
Maple syrup urine disease: analysis of branched chain ketoacid decarboxylation in cultured fibroblasts. Pediatr Res (1975) 0.96
Maple syrup urine disease: favourable effect of early diagnosis by newborn screening on the neonatal course of the disease. J Inherit Metab Dis (2006) 0.96
Simple method for the routine determination of betaine and N,N-dimethylglycine in blood and urine. Clin Chem (1998) 0.95
Is demyelination a feature of maple syrup urine disease? Pediatr Neurol (1994) 0.94
Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification. Mol Genet Metab (2005) 0.93
Pitfalls in measuring plasma cholesterol in the Smith-Lemli-Opitz syndrome. Clin Chem (1997) 0.93
Intellectual performance of children with maple syrup urine disease. Eur J Pediatr (1993) 0.93
Proton magnetic resonance spectroscopy reflects metabolic decompensation in maple syrup urine disease. Pediatr Radiol (1995) 0.90
Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease. Clin Chem (1999) 0.90
Carnitine supplementation induces long-chain acylcarnitine production--studies in the VLCAD-deficient mouse. J Inherit Metab Dis (2006) 0.89
Beta cell nesidioblastosis. Eur J Pediatr (1978) 0.89
Development of height and weight in children with diabetes mellitus: report on two prospective multicentre studies, one cross-sectional, one longitudinal. Eur J Pediatr (1992) 0.88
Diagnostic work-up and management of patients with isolated methylmalonic acidurias in European metabolic centres. J Inherit Metab Dis (2008) 0.88
Identification of four novel mutations in severe methylenetetrahydrofolate reductase deficiency. Eur J Hum Genet (1998) 0.88
Acute neuronopathic Gaucher disease complicated by fatal gastrointestinal bleeding. Neuropediatrics (2006) 0.87
Metabolism of branched-chain amino acids in maple syrup urine disease. Eur J Pediatr (1997) 0.87
Normal clinical outcome in untreated subjects with mild hyperphenylalaninemia. Pediatr Res (2001) 0.87
Defects in the mitochondrial energy metabolism outside the respiratory chain and the pyruvate dehydrogenase complex. Mol Cell Biochem (1997) 0.87
HLA and Wolfram (DIDMOAD) syndrome. Lancet (1983) 0.87
Clinical differences in patients with mitochondriocytopathies due to nuclear versus mitochondrial DNA mutations. Hum Mutat (2000) 0.87
Analysis of the fatty acid composition of erythrocyte phospholipids by a base catalysed transesterification method--prevention of formation of dimethylacetals. Clin Chim Acta (1988) 0.86
Studies on the optimal cooling rate for freezing human diploid fibroblasts. Exp Cell Res (1973) 0.86
beta-Trace protein in human cerebrospinal fluid: a diagnostic marker for N-glycosylation defects in brain. Biochim Biophys Acta (1999) 0.85
Importance of mitochondrial transmembrane processes in human mitochondriopathies. J Bioenerg Biomembr (1996) 0.85
Deficiency of the voltage-dependent anion channel: a novel cause of mitochondriopathy. Pediatr Res (1996) 0.85
Increased manganese content and reduced arginase activity in erythrocytes of a patient with prolidase deficiency (iminodipeptiduria). Eur J Pediatr (1986) 0.85
A familial progressive neurodegenerative disease with 2-oxoglutaric aciduria. Eur J Pediatr (1982) 0.85
Structural white matter changes in adolescents and young adults with maple syrup urine disease. J Inherit Metab Dis (2013) 0.85
Multiple acyl-CoA dehydrogenation deficiency (glutaric aciduria type II), congenital polycystic kidneys, and symmetric warty dysplasia of the cerebral cortex in two brothers. I. Clinical, metabolical, and biochemical findings. Eur J Pediatr (1982) 0.85
Genetic counselling and prenatal diagnosis in disorders of the mitochondrial energy metabolism. J Inherit Metab Dis (1996) 0.84
White matter abnormalities in patients with treated hyperphenylalaninaemia: magnetic resonance relaxometry and proton spectroscopy findings. Eur J Pediatr (1993) 0.84
Description of the mutations in 15 subjects with variant forms of maple syrup urine disease. J Inherit Metab Dis (2007) 0.84
Molecular genetic characterization and urinary excretion pattern of metabolites in two families with MCAD deficiency due to compound heterozygosity with a 13 base pair insertion in one allele. J Inherit Metab Dis (1994) 0.84
Liver transplantation in two cases of propionic acidaemia. J Inherit Metab Dis (1995) 0.84
Clinical heterogeneity in respiratory chain complex III deficiency in childhood. J Neurol Sci (1997) 0.84
Isolated (biotin-resistant) 3-methylcrotonyl-CoA carboxylase deficiency: four sibs devoid of pathology. J Inherit Metab Dis (1995) 0.84
Metabolic phenotypes of phenylketonuria. Kinetic and molecular evaluation of the Blaskovics protein loading test. J Inherit Metab Dis (2009) 0.83
[Diseases caused by genetic defects in lysosomal muco-polysaccharide-catabolism. Mucopolysaccharidoses]. Dtsch Med Wochenschr (1974) 0.82
Prenatal detection of defects in propionate metabolism. Clin Chim Acta (1980) 0.82
Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib. J Pediatr (1991) 0.82
3-Methylglutaconic and 3-methylglutaric aciduria in a patient with suspected 3-methylglutaconyl-CoA hydratase deficiency. Eur J Pediatr (1985) 0.82
Association of malonyl-CoA decarboxylase deficiency and heterozygote state for haemoglobin C disease. J Inherit Metab Dis (1994) 0.82
Prenatal diagnosis for methylenetetrahydrofolate reductase deficiency. J Pediatr (1983) 0.82
Novel mutations in patients with fructose-1,6-bisphosphatase deficiency. J Inherit Metab Dis (1999) 0.81
Maple syrup urine disease: mutation analysis in Turkish patients. J Inherit Metab Dis (2002) 0.81
Intracellular levels and metabolism of leucine and alpha-ketoisocaproate in normal and maple syrup urine disease fibroblasts. Biochem Med (1984) 0.81
Enzymatic method for determination of branched-chain amino acid aminotransferase activity. Anal Biochem (1995) 0.81
Analysis of concentration and (13)C enrichment of D-galactose in human plasma. Clin Chem (2000) 0.81
Cardiomyopathy and pericardial effusion in infancy point to a fatty acid b-oxidation defect after exclusion of an underlying infection. Pediatr Cardiol (2002) 0.81
Glycogenosis type Ib complicated by severe granulocytopenia resembling inherited neutropenia. Eur J Pediatr (1981) 0.80
Purification and some properties of a kininogenase from human plasma activated by surface contact. Hoppe Seylers Z Physiol Chem (1972) 0.80
Maple-syrup-urine disease. N Engl J Med (1983) 0.80
Cerebral metabolic changes in biotinidase deficiency. J Inherit Metab Dis (1997) 0.80
Prenatal treatment of a patient with vitamin B12-responsive methylmalonic acidemia. J Pediatr (1990) 0.80
MR and proton MR spectroscopy of the brain in hyperhomocysteinemia caused by methylenetetrahydrofolate reductase deficiency. AJNR Am J Neuroradiol (1997) 0.79
Correlations between branched-chain amino acids and branched-chain alpha-keto acids in blood in maple syrup urine disease. Clin Chim Acta (1978) 0.79
[Intermittent maple syrup urine disease in a 12-year-old boy: clinical aspects, diagnosis and treatment]. Klin Padiatr (1983) 0.79
Hereditary defect of cobalamin metabolism (homocystinuria and methylmalonic aciduria) of juvenile onset. J Neurol Neurosurg Psychiatry (1996) 0.79
Inflammatory bowel disease in glycogen storage disease type Ib. J Pediatr (1987) 0.79
Dietary long-chain polyunsaturated fatty acid supplementation in infants with phenylketonuria: a randomized controlled trial. J Inherit Metab Dis (2007) 0.79
Age-dependent fatty acid composition of erythrocyte membrane phospholipids in healthy children. Z Ernahrungswiss (1990) 0.79
Molecular analysis in glycogen storage disease 1 non-A: DHPLC detection of the highly prevalent exon 8 mutations of the G6PT1 gene in German patients. Hum Mutat (2000) 0.78
Molecular genetic characterization of maple syrup urine disease in European families. Biochem Med Metab Biol (1993) 0.78
Odd-numbered long-chain fatty acids in propionic acidaemia. Eur J Pediatr (2000) 0.78
Autosomal recessive liver phosphorylase kinase deficiency caused by a novel splice-site mutation in the gene encoding the liver gamma subunit (PHKG2). Biochem Biophys Res Commun (1997) 0.78
[Diagnostic differentiation between precocious puberty and premature thelarche using ultrasonography and the stimulated LH/FSH quotient]. Geburtshilfe Frauenheilkd (1990) 0.78
Postoperative metabolic decompensation in maple syrup urine disease is completely prevented by insulin. J Inherit Metab Dis (1993) 0.78
Renal clearance of branched-chain L-amino and 2-oxo acids in maple syrup urine disease. J Inherit Metab Dis (1999) 0.77